When Does a Narrowed Heart Artery Need a Coronary Stent Rather Than Medicines Alone?

The report is short and the wording is bold: a narrowing in the left anterior descending artery, graded moderate to severe. The man holding it is 61 and has noticed a tightness in his chest on the hill by the park that fades when he stops. He expected to be told he needs a stent. Instead, his cardiologist talked about medicines, a stress test and a follow-up visit, and he left wondering whether something had been missed.

Nothing had. The question of when is a coronary stent needed, rather than medicines alone, has one of the more surprising answers in modern cardiology, because large trials have changed what the profession believes about narrowed arteries in people who are not actually having a heart attack.

This article walks through that evidence, what happens during the procedure, who is usually offered one and who is asked to wait, what recovery looks like, and the questions worth bringing to your next appointment.

What percentage blockage needs a stent? Why the number alone does not decide

A percentage on an angiogram report sounds like a verdict. In practice it is an estimate. A cardiologist injects dye into the artery, watches it flow on an X-ray screen, and judges by eye how much narrower the vessel looks at its tightest point compared with a healthy segment nearby. Two experienced readers can disagree by a meaningful margin on the same image.

The bigger problem is that a percentage describes anatomy, not physiology. What the heart muscle cares about is whether enough blood arrives when it works hard. A long, gently tapering narrowing can starve the muscle downstream more than a short, dramatic-looking pinch. A pressure wire, a thin sensor threaded through the narrowing, measures how much the blockage actually reduces flow, and interventional teams increasingly rely on that reading, together with symptoms and stress testing, rather than the eyeballed percentage alone.

Location matters as much as size. A narrowing at the start of the left main artery, which feeds most of the left ventricle, carries different weight than a similar narrowing in a small branch supplying a sliver of muscle. Cardiology guidelines treat those high-value locations as a separate category, and they often shift the discussion toward opening the artery, sometimes by bypass surgery rather than a stent.

So the honest answer to what percentage blockage needs a stent is that no single number decides. The percentage opens the conversation. Your symptoms, the results of functional tests, where the narrowing sits and how you are doing on medicines finish it. That is why two people with near-identical angiogram reports can leave the same clinic with different, equally reasonable plans, and why the rest of this article spends more time on circumstances than on numbers.

How does a coronary stent actually work?

A coronary stent is a tiny tube of metal mesh, roughly the length of a fingernail, that props open a narrowed artery from the inside. Placing one is called percutaneous coronary intervention, or PCI: percutaneous means through the skin, without opening the chest. Most people know it as angioplasty with stenting.

Here is what usually happens. You lie awake on a table in a catheterization lab, a room built around a movable X-ray camera. Local anesthetic numbs a spot on the wrist or, less often, the groin, and a short sheath goes into the artery there. Through it the cardiologist threads a catheter, a flexible tube narrower than a pencil lead, up to the heart. Contrast dye makes the coronary arteries visible on screen. A guidewire crosses the narrowing, and a deflated balloon slides over it into position.

The balloon inflates for a few seconds, pressing the plaque against the artery wall; a brief chest tightness at that moment is common. The stent, mounted on the balloon, expands with it and locks in place. The balloon deflates and comes out; the stent stays, permanently. Most modern stents are drug-eluting, coated with a medicine that releases slowly to discourage scar tissue from growing back into the channel. Over the following weeks the artery’s inner lining grows over the mesh, which is one reason antiplatelet medicines are so important in that early period.

The NHS describes the procedure as typically taking between 30 minutes and two hours, depending on how many narrowings are treated and how complex they are. Afterward the sheath is removed and pressure or a small closure device seals the puncture.

One distinction shapes everything that follows: a stent does not remove plaque. It moves the plaque aside and holds the road open at that one spot.

When is a coronary stent needed right away? Heart attacks and unstable symptoms

The clearest case for a stent is the one where there is no time to weigh options. In a heart attack, a plaque cracks open and a blood clot forms on the raw surface, blocking the vessel. Muscle downstream begins to die within minutes. The most severe form, called a STEMI after the ECG pattern it produces, usually means a completely blocked artery.

For a STEMI, guidelines around the world agree that reopening the artery mechanically, a procedure called primary PCI, is the preferred treatment when it can be delivered quickly. NHS guidance describes primary PCI as the first choice within the first 12 hours after symptoms begin, provided it can be performed within about two hours of the point at which a clot-dissolving drug could otherwise have been given. When a catheterization lab is too far away, the clot-dissolving medicine is given first. Clinicians summarize the principle as time is muscle.

A second urgent group has a partly blocked artery and a smaller heart attack, called an NSTEMI, or unstable angina, meaning chest symptoms that are new, escalating or occurring at rest. These patients are usually admitted, started on antiplatelet and anticoagulant medicines, and taken for an angiogram within hours to a few days depending on risk. Many receive a stent during that admission because the plaque that caused the trouble is judged likely to cause more.

In these situations the question of when is a coronary stent needed largely answers itself. The artery is not simply narrowed; it is actively injuring the heart. Medicines still matter enormously, but they are given alongside the procedure, not instead of it. The real debate about stents versus medicines alone belongs to the next scenario: stable disease, where nothing is acutely on fire.

When is a coronary stent needed for stable angina? What the trials showed

Stable angina is chest pressure, or sometimes breathlessness or arm and jaw discomfort, that arrives predictably with exertion or stress and eases with rest. The narrowing is real, but the plaque is not rupturing. For decades the intuitive view was that a narrow pipe should be opened. The trials told a more complicated story.

The largest, indexed on PubMed, was the ISCHEMIA trial. It enrolled 5,179 people with stable coronary disease and moderate or severe reduced blood flow on a stress test, and randomly assigned them either to an early invasive strategy of angiography followed by stenting or bypass where suitable, plus medicines, or to medicines alone with procedures reserved for those whose symptoms failed to settle. After a median follow-up of 3.2 years, the combined rate of cardiovascular death, heart attack and hospitalization for unstable angina, heart failure or cardiac arrest was not significantly different between the two groups.

What did differ was symptoms. Participants who had angina at the start reported more relief and better quality of life with the invasive strategy, an effect most noticeable in people with frequent angina and smallest in those who had little or none. Earlier trials had pointed the same way: in stable disease, stents relieve angina but have not been shown to prevent death or heart attack beyond what good medicines achieve.

That is why current guidelines frame the decision as symptom-driven. A stent for stable angina is mainly considered when angina keeps limiting a person’s life despite a proper trial of medicines, when medicines cannot be tolerated, or when testing reveals high-risk anatomy such as significant left main disease. Otherwise, starting with medicines is not a lesser path. It is the path the evidence supports, with a stent kept in reserve.

Stent vs medication for angina: what the medicines actually do

Medicines alone is a misleading phrase, because it sounds passive. What cardiologists call optimal medical therapy is an active program that works on several fronts at once, and each drug class has a specific job. The classes below are described for understanding only; what you take, and how much, is entirely a matter for your prescribing clinician.

• Statins lower LDL cholesterol and, over months to years, appear to make plaques more stable and less likely to rupture. Their benefit builds with time rather than arriving overnight.
• Antiplatelet medicines, such as aspirin, make platelets less sticky so a cracked plaque is less likely to seed a clot. This is prevention of the heart attack itself, not relief of angina.
• Beta blockers slow the heart and reduce how forcefully it contracts, lowering oxygen demand so a narrowed artery can keep up. Their anti-anginal effect typically appears over days to weeks.
• Nitrates relax and widen blood vessels; short-acting forms ease an attack, long-acting forms help prevent them.
• Calcium channel blockers widen arteries and, in some types, slow the heart; they serve as an alternative or addition when beta blockers are unsuitable.
• Blood pressure medicines such as ACE inhibitors reduce strain on the heart and protect the kidneys, particularly in people with diabetes.

Alongside these sit the unglamorous levers: stopping smoking, controlling blood pressure and glucose, regular activity and cardiac rehabilitation. In the trials described above, this combination matched an early stent strategy on the outcomes that matter most.

The comparison, then, is never stent versus nothing. A stent addresses one narrowing in one spot. Medicines treat the disease process along the whole coronary tree, including plaques too small to see. Everyone who receives a stent takes these same medicines afterward. The real question is whether adding the procedure to the medicines buys enough extra benefit for you, right now.

Who is usually offered a stent, and who is usually asked to wait?

Cardiology teams do not follow a single rule, but a recognizable pattern emerges from guidelines and from the way the evidence shapes practice.

A stent is commonly offered when:

• You are having a heart attack or have unstable angina, and an angiogram shows a culprit lesion that can be treated.
• Stable angina keeps limiting daily life despite a fair trial of anti-anginal medicines.
• Anti-anginal medicines cause side effects you cannot live with, such as fatigue or dizziness that stops you functioning.
• Non-invasive tests show a large area of heart muscle short of blood, and pressure-wire measurements confirm the narrowing is the reason.
• A critical narrowing sits in a location that supplies a great deal of muscle, and surgery is judged unsuitable or you have decided against it after discussion.

Medicines first is commonly advised when:

• Angina is mild, infrequent or well controlled.
• Stress testing shows only a small amount of muscle affected, or the narrowing turns out not to restrict flow when measured directly.
• The narrowing sits in a small branch where a stent would protect little muscle yet carry the same procedural risks.
• Other conditions, such as advanced kidney disease or a high bleeding risk, make the procedure or the antiplatelet medicines after it more hazardous.
• Disease is extensive across several arteries or involves the left main, where bypass surgery may serve better and the question becomes stent or surgery rather than stent or medicines.

Age alone rarely decides. Older adults with disabling angina are often offered stents, while younger people with quiet, stable disease are often asked to give medicines a proper chance. What the team weighs is how much the narrowing is hurting you now against what the procedure could realistically add. That balance belongs in a conversation where you can say, plainly, how much your symptoms bother you.

How do cardiologists decide? The tests beyond the angiogram

An angiogram is the map, but the team usually wants to know how the traffic actually flows before deciding whether to widen a lane. Several tests do that job, and each answers a slightly different question.

A stress test, whether on a treadmill, on a bike or with a medicine that mimics exercise, asks the heart to work hard while an ECG, an ultrasound or a nuclear scan watches for signs that part of the muscle is not getting enough blood. The amount of muscle affected, not just whether the test is positive, feeds the decision. A large territory at risk pushes toward intervention; a small one usually does not.

CT coronary angiography uses a scanner and contrast dye to picture the arteries without a catheter. It is good at ruling disease out and at spotting plaque, though it tends to overestimate how tight a narrowing is when calcium is present.

Inside the cath lab, two tools refine the picture. Fractional flow reserve, or FFR, uses a pressure wire to compare blood pressure beyond the narrowing with pressure before it; a large drop means the lesion is genuinely limiting flow. Intravascular ultrasound and optical coherence tomography place a tiny imaging probe inside the artery to measure the true channel size and see the plaque’s structure. When these tools show a narrowing that looks bad but flows well, teams often leave it alone and rely on medicines, a strategy that trials have supported.

Kidney function, an echocardiogram of the heart’s pumping strength and your overall health complete the file. The recommendation, whether stent, surgery or medicines with review, comes from that whole picture, usually discussed among cardiologists and, for complex cases, with a cardiac surgeon at the table.

Stent, medicines alone or bypass surgery: how the options compare

Three broad paths exist for a narrowed coronary artery, and each has a place. The table summarizes how they differ in everyday terms; none of it replaces the judgment of a team that has seen your angiogram.

Approach	What happens	Typically considered when	Main advantages	Main trade-offs
Medicines plus lifestyle (optimal medical therapy)	Antiplatelets, statins, anti-anginals and risk-factor control, reviewed regularly	Stable angina that is mild or controlled; small area of muscle at risk; high procedural risk	Treats the whole coronary tree; no procedural risk; matched invasive strategies on death and heart attack in stable disease	Angina may persist; requires long-term adherence; a stent may still be needed later
Angioplasty with stent (PCI)	Catheter via wrist or groin; balloon and mesh tube hold one segment open	Heart attack; unstable angina; stable angina despite medicines; one or a few lesions	Rapid symptom relief; minimally invasive; short hospital stay	Treats only the stented spot; procedural risks; antiplatelet medicines required afterward; re-narrowing possible
Coronary bypass surgery (CABG)	Open-chest operation that grafts new vessels around blockages	Extensive multi-vessel disease; left main disease; diabetes with several blockages; lesions unsuitable for stents	Treats several arteries in one operation; durable in complex disease	Major surgery with a considerably longer recovery; higher short-term risk; not suitable for everyone

Three points deserve emphasis. First, the paths are not mutually exclusive: everyone who has a stent or an operation also needs the medicines. Second, choosing medicines first does not close the door; in the stable-disease trials, people whose symptoms persisted moved to a procedure later, and the overall outcomes of the medicines-first groups were not worse. Third, stent versus surgery is a separate question with its own evidence, usually raised when disease is widespread, and it is where a heart team discussion involving a surgeon becomes standard practice.

Coronary stent risks and benefits, honestly weighed

Any honest conversation about stents puts the benefits and the risks on the same page. Both are real, and both depend heavily on why the stent is being placed.

The benefit is largest in a heart attack, where reopening the artery limits the muscle lost and improves survival compared with leaving the artery closed, according to guideline-level evidence. In stable angina the benefit is chiefly symptomatic: less chest pressure, more freedom to walk, climb and work. That is not trivial; it is simply a different kind of gain than preventing a heart attack, and it is worth being clear-eyed about which one you are being offered.

The risks fall into groups. At the access site, bruising or bleeding is the most common problem and is usually minor; wrist access has reduced but not eliminated it. Contrast dye can strain the kidneys, particularly if they are already weakened, and can occasionally trigger an allergic reaction. The procedure uses X-rays, so there is a small radiation exposure. Inside the artery, the wire or balloon can occasionally tear the vessel wall or dislodge debris. Serious complications, including heart attack caused by the procedure, stroke and death, are uncommon but not zero, and they rise with age, kidney disease, complex anatomy and emergency circumstances.

Two stent-specific problems matter afterward. Restenosis is scar tissue growing back into the stent and re-narrowing it; drug-eluting stents were designed to reduce this, which is why they dominate current practice. Stent thrombosis is a clot forming on the stent itself, a rare but dangerous event that becomes markedly more likely if antiplatelet medicines are stopped early without medical advice.

Your team should be able to translate these general risks into your personal situation. Asking them to do so, out loud, is entirely reasonable.

Angioplasty and stent recovery time: the first days and weeks

Recovery after a planned stent is usually short, though a stent placed during a heart attack sits inside the longer recovery from the heart attack itself.

After the procedure you lie flat for a while if the groin was used, or wear a compression band on the wrist. Nurses check the puncture site and your pulse repeatedly. The NHS describes most people who have a planned angioplasty going home the same day or the following day, with longer stays when the procedure was an emergency. You will need someone to take you home.

In the first week, expect a bruise at the access site and some tenderness. The NHS advises avoiding driving for about a week after a planned procedure and for longer after a heart attack, and avoiding heavy lifting or strenuous exercise until the puncture has healed. Licensing rules vary by region, so ask your team what applies where you live. Most people who had a planned procedure can return to desk work within about a week, again per NHS guidance, while physically demanding jobs take longer and depend on how the heart is doing.

Over the following weeks, two things matter more than rest. One is taking the antiplatelet medicines exactly as prescribed, because the artery lining is still growing over the stent. The other is cardiac rehabilitation, a supervised program of exercise, education and support that guidelines recommend after stenting and that many people skip. Rehabilitation is where medicines, activity and confidence come together, and where you learn what your new normal looks like.

Follow-up includes a clinic review of the wound, your symptoms and your medicines. Angina that returns after a period of relief should be reported, not tolerated.

Life after a stent: why the medicines do not stop

A stent treats a segment of artery a few millimeters long. Coronary disease is a process affecting the whole vessel network, driven by cholesterol, blood pressure, smoking, diabetes and inflammation. That mismatch is why the medicines continue after the procedure, often for life.

The most time-sensitive are the antiplatelets. After a stent, people commonly take two together, aspirin plus a second agent from the P2Y12 inhibitor class, an approach called dual antiplatelet therapy. The NHS describes this combination continuing for up to about a year after a stent, after which many people continue a single agent long term. The exact duration is a decision your cardiologist makes based on your bleeding risk, the reason for the stent and the type of stent used. Stopping early, including for dental work or another operation, should never happen without checking with the cardiology team first; other clinicians can coordinate around the medicines rather than simply pausing them.

Statins and blood pressure medicines continue because they slow the disease everywhere else. Anti-anginals may be reduced if symptoms have resolved, but only by the prescriber.

Practical worries are common and mostly reassuring. Modern coronary stents are generally considered safe in MRI scanners, though you should always tell the radiology team you have one. Airport security scanners do not affect them. You may be given a card describing the stent; keep it with your identification.

The habits matter as much as the tablets. Not smoking, moving daily, eating in a heart-healthy pattern and attending rehabilitation are the interventions that work on the plaques no one can see, which is where the next problem, if there is one, would begin.

What people often get wrong about stents

Myths cluster around stents, partly because the procedure is so vivid. A blocked pipe, a balloon, a scaffold: the metaphor is satisfying, and it is where most misunderstandings start.

The blockage was the problem, so the stent fixed it. A stent treats one narrowing. Many heart attacks begin at plaques that were not the tightest on the angiogram but were the most unstable, which is why medicines that stabilize plaque everywhere remain central.

Being told to start with medicines means the doctors are giving up. In stable disease, medicines first is the strategy the largest trials support on the outcomes that matter most. It is the evidence-based default, not a consolation prize.

A stent prevents heart attacks. During a heart attack, opening the artery limits damage. In stable angina, trials have not shown that stents reduce future heart attacks or deaths compared with good medical therapy; what they reliably do is relieve angina.

A higher percentage automatically means a stent. The eyeballed percentage is imprecise and says nothing about flow. Pressure-wire measurements sometimes show that a dramatic-looking narrowing is not limiting blood supply, and vice versa.

Once the stent is in, the medicines can stop. The opposite is true in the early months, when stopping antiplatelets is the single most avoidable cause of stent clotting.

Stents wear out or need replacing. The mesh is permanent. Re-narrowing can occur and new disease can develop elsewhere, but the device itself has no service life.

Because it was done through the wrist, it was minor. The access is small; the territory is not. Follow-up, rehabilitation and medicines deserve the same seriousness as after any heart procedure.

Questions to ask your care team

The best decisions about stents happen in conversations, and conversations go better when you arrive with questions. These are ones cardiologists are used to hearing and generally welcome.

• Is my situation urgent, or do we have time to try medicines first and see how I respond?
• Which of my symptoms would the stent be expected to improve, and which would it not change?
• Is the goal of this procedure to relieve angina, to lower my risk of a heart attack, or both? What does the evidence say for someone like me?
• How much heart muscle does this narrowing supply, and did a stress test or pressure wire confirm that it is restricting flow?
• If I choose medicines first, what would make you want to reconsider, and how soon would we review?
• Am I a candidate for bypass surgery instead, and has a surgeon been part of the discussion?
• What are my personal risks from the procedure, given my kidneys, my age and my other conditions?
• Which medicines will I need afterward, for roughly how long, and who do I contact before any other clinician suggests stopping one?
• What will recovery look like for my job and my daily activities?
• Will I be referred to cardiac rehabilitation, and when would it start?
• If the angina comes back, what should I do first?

Bring someone with you if you can, and write the answers down. It is entirely reasonable to ask for a day or two to think when the situation is stable, and equally reasonable to trust the team when they explain that it is not. The decision belongs to you and your treating team together, and a good team will make that clear without being asked.

When to call your doctor

Some symptoms belong in an emergency call, not a message to the clinic, whether or not you have a stent.

Call emergency services immediately if you develop chest pressure, tightness or pain that lasts more than a few minutes or comes and goes, especially if it spreads to the arm, jaw, neck or back, or arrives with sweating, nausea, breathlessness or lightheadedness. After a stent, this pattern can signal a clot on the stent and needs a hospital, fast. Do the same for sudden severe breathlessness, fainting, a fast irregular heartbeat with faintness, or signs of stroke such as facial drooping, arm weakness or slurred speech. Do not drive yourself.

Contact your cardiology team the same day if the puncture site bleeds and does not stop with firm pressure for several minutes, if a lump at the site grows rapidly or becomes very painful, if the hand or leg beyond it turns cold, pale or numb, or if you notice fever, spreading redness or discharge suggesting infection. Call, too, if vomiting or diarrhea may have caused you to miss or lose antiplatelet doses, or if any other clinician asks you to stop a heart medicine.

Book a prompt appointment if angina that had settled begins to return, if you need your short-acting nitrate more often than before, if your exercise tolerance is falling, or if side effects are tempting you to stop a medicine. Never stop or adjust a prescribed medicine on your own; a phone call can usually find an alternative.

If you have not been offered cardiac rehabilitation or a follow-up appointment, ask. Those two things are part of the treatment, not extras.

Frequently asked questions

Stent vs medication for angina: which controls symptoms better?

In stable angina, a stent generally relieves chest symptoms faster and more completely than medicines alone, particularly for people with frequent angina. Medicines also reduce angina, and in the ISCHEMIA trial they matched the invasive strategy on death and heart attack. The choice usually rests on how much angina limits your life after a fair trial of medicines, a judgment for you and your cardiologist together.

What percentage blockage needs a stent?

There is no single percentage that automatically requires a stent. The figure on an angiogram is an estimate of how narrow the vessel looks, not a measure of how much blood gets through. Cardiologists combine it with your symptoms, stress test results, pressure-wire measurements and the location of the narrowing. A tight-looking lesion that flows well is often managed with medicines; a moderate one that starves muscle may be treated.

What is the typical angioplasty and stent recovery time?

After a planned angioplasty, the NHS describes most people going home the same day or the next, avoiding driving for about a week, and returning to non-strenuous work within roughly a week. Heavy lifting waits until the puncture site heals. A stent placed during a heart attack sits inside a longer recovery, and cardiac rehabilitation usually begins over the following weeks. Your team sets the timeline for your circumstances.

What are the main coronary stent risks and benefits?

The main benefit in a heart attack is limiting muscle damage; in stable angina it is symptom relief. Risks include bleeding or bruising at the wrist or groin, kidney strain from contrast dye, small radiation exposure, and uncommon but serious events such as artery damage, heart attack, stroke or death. Later risks are re-narrowing inside the stent and, rarely, a clot on it, especially if antiplatelet medicines stop early.

Can a narrowed artery get better with medicines alone?

Medicines rarely make a narrowing disappear, but they change what matters most. Statins lower cholesterol and appear to stabilize plaque so it is less likely to rupture, antiplatelets reduce clot formation, and anti-anginals lower the heart’s oxygen demand so symptoms ease. Large trials in stable disease show this approach matches an early stent strategy on death and heart attack, which is why guidelines often recommend it first.

Does a stent prevent a heart attack?

During a heart attack, a stent that reopens the blocked artery limits damage and is standard treatment. In stable angina, however, trials have not shown that stents prevent future heart attacks or deaths compared with good medical therapy. That is because most heart attacks start at unstable plaques rather than the tightest narrowing, and a stent treats only one spot while medicines act on the whole artery network.

How long does a coronary stent last?

The stent itself is permanent and does not wear out or need replacing. Over weeks the artery lining grows over the mesh and it becomes part of the vessel wall. What can change is the artery: scar tissue may re-narrow the stented segment, and new plaque can form elsewhere. Continuing prescribed medicines and addressing risk factors is how that ongoing disease is managed.

Can I have an MRI with a coronary stent?

Modern coronary stents are generally considered safe in MRI scanners, and many people have scans without any problem. You should always tell the radiology team that you have a stent and, if possible, carry the card describing it so they can confirm the details. Airport security scanners and everyday electronics do not affect coronary stents.

Why would a cardiologist recommend bypass surgery instead of a stent?

Bypass surgery is usually considered when disease is extensive across several arteries, when the left main artery is significantly narrowed, when a person with diabetes has multiple blockages, or when lesions are technically unsuitable for stents. Surgery treats several vessels in one operation but involves a much longer recovery and higher short-term risk. These cases are typically reviewed by a heart team that includes both cardiologists and a surgeon.

What happens if I choose medicines first and my angina gets worse?

Choosing medicines first does not close the door to a stent. Guidelines and the major stable-disease trials both built in the option of moving to angiography and stenting if symptoms persist or worsen despite treatment. Report returning or escalating angina promptly rather than tolerating it, and seek emergency care for chest pain that lasts more than a few minutes or occurs at rest, since that may signal an unstable plaque.

References

• NHS: Coronary angioplasty and stent insertion
• NHS: Heart attack, treatment
• MedlinePlus: Angioplasty and stent placement, heart
• PubMed: Initial invasive or conservative strategy for stable coronary disease (ISCHEMIA trial)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.